Medpace Holdings Inc sell UBS Group AG
Start price
29.07.25
/
50%
€377.20
Target price
29.07.26
€263.00
Performance (%)
2.07%
Price
20.02.26
€385.00
Summary
This prediction is currently active. With a performance of 2.07%, the SELL prediction by UBS_Group_AG for Medpace Holdings Inc is trending in the wrong direction This prediction currently runs until 29.07.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Medpace Holdings Inc | 6.767% | 6.767% |
| iShares Core DAX® | 1.432% | 2.628% |
| iShares Nasdaq 100 | 1.892% | -0.458% |
| iShares Nikkei 225® | -1.619% | 11.097% |
| iShares S&P 500 | 1.921% | 1.159% |
Comments by UBS_Group_AG for this prediction
In the thread Medpace Holdings Inc diskutieren
Medpace Holdings, Inc. (NASDAQ: MEDP) was downgraded by analysts at UBS Group AG from a "neutral" rating to a "sell" rating. They now have a $305.00 price target on the stock.
Ratings data for MEDP provided by MarketBeat
Stopped prediction by UBS_Group_AG for Medpace Holdings Inc
Medpace Holdings Inc
Start price
Target price
Perf. (%)
€369.50
15.02.24
15.02.24
€419.64
15.02.25
15.02.25
-11.48%
16.02.25
16.02.25
